Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Easy Diagnosis Biomedicine is a China-based public diagnostics company focused on in vitro diagnostic reagents, instruments, and point-of-care testing solutions. The company develops, manufactures, and markets products across blood gas analysis, immunodiagnostics, molecular diagnostics, and coagulation analysis, and also provides related diagnostic services and medical information platform offerings. Its products are used by thousands of medical institutions and sold across China and more than 50 countries and regions. The business is best characterized as a commercial-stage IVD and medical technology company rather than a therapeutics developer, with particular strength in rapid diagnostics and hospital-facing testing systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Easy Diagnosis Biomedicine.